RonaldSLeuchterMD

Obstetrics & Gynecology • Los Angeles, CA

Gynecologic Oncology, Minimally Invasive / Endoscopic Surgery

Associate Professor of Obstetrics & Gynecology, UCLA

Join to view full profile

Dr. Leuchter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leuchter's full profile

Already have an account?

Office
8700 Beverly Blvd
Los Angeles, CA 90048
Phone+1 310-423-0701

Fax+1 310-967-1142

Summary

I did General Practice in Vancouver BC until 1974 then a residency at Cedars Sinai and UCLA in Los Angeles to 1978, followed by fellowship in Gynecologic Oncology at UCLA to 1980. Fulltime academics at UCLA until 1986 as well as Director of Gyn. Oncology at Cedars Sinai. Associate Clinical Professor at UCLA. Clinical academic practice to 2019 and now retired.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 1978 - 1980
Cedars-Sinai Medical CenterResidency, Obstetrics and Gynecology, 1975 - 1978
University of Toronto Faculty of MedicineClass of 1970

Certifications & Licensure

CA State Medical License 1975 - 2025
FL State Medical License 2013 - 2015
NV State Medical License 1993 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Fellow American College of SurgeonsObstetrics and Gynecology

Awards, Honors, & Recognition

Ronald S. Leuchter MD. Award in Gynecologic Oncology
Ronald S. Leuchter Award in Gyncologic Oncology CSMC CSMC
Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Publications & Presentations

PubMed

32 citations
A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
Sally Mortlock, Rosario I Corona, Pik Fang Kho, Paul Pharoah, Ji-Heui Seo
Cell Reports. Medicine. 2022-03-15
102 citations
Effect of obesity on survival in epithelial ovarian cancer.
James C. Pavelka, Rebecca S. Brown, Beth Y. Karlan, Ilana Cass, R.S. Leuchter
Cancer. 2006-10-01
2 citations
Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignancies
John C. Elkas, Jonathan S. Berek, R.S. Leuchter, Leo D. Lagasse, Beth Y. Karlan
Gynecologic Oncology. 2005-05-01

Journal Articles

Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cancer.
Cass I., Varkey T., Baldwin R.L., Moslehi R., Narod S.A., Leuchter R.S., Lagasse L.D. and Karlan B.Y., Proc AACR 1069, 42:200
Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles.
Ioffe YJM, Li AJ, Walsh CS, Karlan BY, Leuchter RS, Forscher C, Cass I., Gynecol Oncol. 115(3):466-71, 12/2009
Effect of obesity on survival in epithelial ovarian cancer.
Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ, Cancer 107:1520-1524, 2006
Effect of obesity on survival in epithelial ovarian cancer.
Pavelka J.C., Brown R.S., Karlan B.Y., Cass I., Leuchter R.S., Lagasse L.D., Li A.J., Cancer 107:1520-1524, 2006
Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignancies.
Elkas JC, Berek JS, Leuchter R, Lagasse LD, Karlan BY, Gynecol Oncol 97:685-692, 2005
Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BYThe prognostic significance of thromboyctosis in epithelial ovarian carcinoma.
Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY, Gynecol Oncol 92:211-214, 2004
Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cancer.
Cass I., Varkey T., Baldwin R.L., Moslehi R., Narod S.A., Leuchter R.S., Lagasse L.D. and Karlan B.Y., Gynecol Oncol 80(2):322,, 3/2002
Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecology oncolgy
Cass I., Li A.J., Runowiz C.D., Fields A., Goldberg G., Lagasse L.D., Leuchter R.S., Karlan B.Y., 80 (1) 56-61, 2001
Interstitial high-dose-rate brachytherapy using remote after loaded plyethylene tubes and a high-activity Iridim-192 source for incompletely resected gynecologic malig...
Casey C.A., Tassin J, Greenberg S., Palmer D, Leuchter R.S., Lagasse L.D., Karlan B.Y., Journal of Gyn Techniques 201-206, 1995
Use of the peritoneal porta-catheter for intraperitoneal chemotherapy.
Schink J., Karlan B.Y., Leuchter R.S., Futoran R.J., Lagasse, L.D., Gynecologic Oncology, 1990
Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival.
Berek J.S., Hacker N.F., Fu Y.S., Sokale J.R., Leuchter R.S., Lagasse L.D., Obstet Gynecol 65 : 46-52, 1985
Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival.
Berek J.S., Hacker N.D., Fu Y.S., Sokale J.R., Leuchter R.S., Lagasse L.D., Obstet Gynecol 64: 837-834, 1984
Lorazepam for chemotherapy-induced emesis. Letter to the editor.
Greenspoon J., Leuchter R.S., Semrad N., Arch Intern Med 144 : 2432, 1984
Primary carcinoma Bartholin's gland: A report of 14 cases and review of the literature.
Leuchter R.S., Hacker N.F., Voet R.L., Berek J.S., Townsend D.E., Lagasse L.D., Obstet Gynecol 60 (3): 361, 1982
Urologic operations as part of cytoreductive surgery for ovarian cancer.
Berek J.S., Hacker N.F., Leuchter R.S., Lagasse L.D., Byron R.l., Gynecol Oncol 13: 87, 1982
Join now to see all

Books/Book Chapters

Controversy in Obstetrics and Gynecology III
Chapter: Antepartum assessment of the fetus.
Leuchter R.S., Shifrin B.S.W.B. Saunders Company
OB-GYN for Medical Students.
Chapter: Uterine corpus cancer.
Leuchter R.S., Wade M.EW.B. Saunders Company1994
OB-GYN for Medical Students.
Chapter: Gynecologic operations
Leuchter R.S., Harris GW.B. Saunders Company, Philadelphia1984
OB-GYN for Medical Students.
Chapter: Uterine corpus cancer.
Leuchter R.S., Wade M.E.W.B. Saunders Company, Philadelphia1984
Join now to see all

Lectures

Current Evaluation and Management of Adenocarcinoma of the Uterus
Grand Rounds – Cedars Sinai Medical Center
The Role of Tumor Markers and Evaluation of Current Treatment Methods
Grand Rounds – Cedars Sinai Medical Center
DES Lecture Series – “DES Update 1981”
September 18, 1981 – Fresno, California
Gestational Trophoblastic Disease”
Kern County Ob-Gyn Conference
Oncology Nursing Seminar – An Overview on Gynecologic Oncology.
Cedars-Sinai Medical Center. Los Angeles, California.
Felmming N.....Leuchter Rl. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinom?
Oral presentation at the joint meeting of WAGO and SGO of Canada, Vancouver, British Columbia - 6/2009
Delic L.....Leuchter R. Brachytherapy Versus External Beam Radiation Therapy in High Intermediate Risk Endometrial Cancer Patients.
Presentation at the Western Association of Gynecologic Oncologists, Sonoma, California - 6/2008
Ioffe Y......Leuchter R. Hormonal Therapies Demonstrate High Response Rates in Treatment of Recurrent Uterine Sarcoma.
Presentation at the Western Association of Gynecologic Oncologists, Sonoma, California - 6/2008
Axtell A.....Leuchter R. Oral Morbidity and mortality of early cervical cancer patients treated with radical hysterectomy followed by adjuvant radiation.
Presentation at the Western Association of Gynecologic Oncologists, Lake Tahoe, California - 5/2006
Walsh C.....Leuchter R. Predictors of recurrence in endometrial cancer.
GlaxoSmithKline Fellows Forum - 3/2004
Li A.....Leuchter r. Predictors of successful secondary cytoreduction in recurrent epithelial ovarian carcinoma.
Oral presentation at 32nd annual meeting of WAGO, Steamboat Spring, CO - 6/2003
Cass I..... Leuchter R. Coexisting ovarian malignancy in young women with endometrial cancer.
Poster presentation at SGO 34th Annual Meeting, New Orleans, Louisiana - 1/2003
Cass I.....Leuchter R. Coexisting Ovarian Malignancy in Young Women with Endometrial Cancer.
Society of Gynecologic Oncologists, New Orleans, Louisiana - 1/2003
Current Concepts in Uterine Cancer and Therapeutic Lymphadenectomy.
OB-GYN Resident Conference - 11/1/2002
Madden A.....Leuchter R. Prognostic Significance and Survival Impact of Second Look Surgery in Optimally Cytoreduced Advanced Stage Ovarian Cancer Patients.
Oral Presentation at Western Association Gynecolgic Oncologists Newport Beach, California - 6/12/2002
Tiue K.....Leuchter R. Clinical Outcome of Young Women with Endometrial Carcinoma.
Oral Presentation at Western Association Gynecologic Oncologist Newport Beach, California - 6/12/2002
Update on Surgery and Gynecologic Cancers “Current Concepts of Endometrial Cancer Screening and Treatment” “Role of Centinal Lymph Nodes in Gynecologic Oncology” “Vide...
Mexico OB-GYN Society, Guadalajara, Mexico. - 6/6/2002
Madden A.....Leuchter R. Prognostic Significance and Survival Impact of Second Look Surgery in Optimally Cytoreduced Advanced Stage Ovarian Cancer Patients
Western Association of Gynecologic Oncologists, Newport Beach, California - 6/2002
Clinical behavior or BRCA-associated ovarian carcinomas.
Oral presentation at WAGO Annual Meeting, Monterey, California - 5/2002
Li A.....Leuchter R. The prognostic significance of thrombocytosis in epithelia ovarian cancer.
Poster presentation at Society of Gynecologic Oncologists 33rd Annual Meeting, Miami Beach, Florida - 3/2002
Cass I.....Leuchter R. Second Look Surgery as a Prognostic Tool for Optimally Cytoreduced Ovarian Carcinoma Patients.
Society of Gynecologic Oncologists Miami Beach, Florida - 3/2002
Cass I.....Leuchter R. Second look surgery as a prognostic tool for optimally cytoreduced ovarian carcinoma patients. Miami Beach, Florida, March 2002.
Poster presentation at Society of Gynecologic Oncologists 33rd Annual Meeting Miami Beach, Florida - 3/2002
Li A.....Leuchter R. The prognostic significance of thrombocytosis in epithelial ovarian cancer.
Oral presentation at Western Association of Gynecologic Oncologists Annual Meeting, Sun Valley Idaho - 6/2001
Li A......Leuchter R. The Prognostic Significance of Thrombocytosis in Epithelial Ovarian Carcinoma.
Western Association of Gynecologic Oncologists. Sun Valley, Idaho - 6/2001
Cass I.....Leuchter R. Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cance
Poster presentation at Association of Cancer Research Annual Conference, New Orleans, Louisiana - 3/2001
Join now to see all

Research History

Co-InvestigatorThe Gilda Radner Hereditary Cancer Program (IRB #1080, 4049) Blood, Tissue and Clinical Data Collection for Cancer Research / Gynecologic Tissue and Clinical Database Core Facility “Gynecologic Tissue Bank”(IRB#0901)2003 - Present
Co-Investigator or Sub-InvestigatorMultiple phase II and phase III GOG sponsored and industry-sponsored gynecologic oncology research protocols including treatment for first-line and recurrent ovarian, fallopian tube and primary peritoneal cancers, and advanced endometrial cancers.2003 - Present
Principal InvestigatorA Randomized First Line Treatment Utilizing Intraperitoneal Platinum and Etoposide versus Intravenous Platinum and Cytoxan in Ovarian Cancer.1986 - Present